3 new IPOs this week, 2 mainboard listings; key details
Pune-based Emcure Pharmaceuticals and Ghaziabad-based Bansal Wire Industries to launch their public issues this week; Ambey Laboratories to open in the SME segment
Pune-based Emcure Pharmaceuticals and Ghaziabad-based Bansal Wire Industries to launch their public issues this week; Ambey Laboratories to open in the SME segment
SEBI says in call auctions, orders are being placed at higher prices in large volumes and a significant portion is cancelled just before closure of a session, which manipulates prices
The IPO of Le Travenues Technology comprises a fresh issue of equities worth ₹120 crore and OFS of ₹620 crore by existing shareholders.
Indegene, Aadhar Housing Finance, and TBO Tek look to collectively raise around ₹5,200 crore via IPO route.
Post listing, Bharti Hexacom shares surged as much as 35% to hit a high of ₹769 on the NSE, while it touched a high of ₹768.95 on the BSE.
P N Gadgil Jewellers looks to raise up to ₹1,100 crore via the IPO route, while Crizac plans to garner up to ₹1,000 crore from the public issue.
Among main board IPOs, the public issue of ₹4,326 crore by Mankind Pharma was the largest in FY24, followed by Tata Tech (₹3,043 cr) and JSW Infra (₹2,800 cr).
The IPO is completely an OFS of 15% stake by the Government of India through Telecommunication Consultants of India.
Krystal Integrated Services raised ₹300 crore from IPO, which was subscribed 13.49 times
The IPO of Transrail Lighting is a combination of fresh equities and OFS components, while Manba Finance looks to raise capital entirely via fresh equity shares.